AbbVie Inc. (NYSE:ABBV) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, the ...

ABBV's growing oncology portfolio, now spanning five therapies, is helping offset Imbruvica's sales decline and boost ...

Pedro Valencia, VP, asset strategy leadership, oncology, AbbVie, explains how the company is advancing Temab-A across multiple tumor types targeting c-Met, with the goal of establishing it as a ...

Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Experience healthcare exec Tameeka Smith appointed CEO of CQ fluency, as founder Elisabete Miranda transitions to Board ...

The 2025 report highlights China’s rapid biopharma rise, along with steady global growth and booming biologics   LONDON – 24 June 2025 – Evaluate, the leading provider of market insights for the ...

The White House is reportedly considering measures to limit pharma companies’ ability to conduct so-called direct-to-consumer advertising. Senators introduced a bill this month that would ban the ...

Functional MRI studies have established that subjective feelings of pain and fatigue have objective correlates in terms of ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...